Antibodies to a new antigen induced by Epstein-Barr virus in patients with nasopharyngeal carcinoma, leukemia, malignant lymphoma, and in control groups.
D000328:Adult; D000906:Antibodies / Q000032:analysis*; D000941:Antigens; D000956:Antigens, Viral; D002277:Carcinoma / Q000276:immunology*; D005455:Fluorescent Antibody Technique; D006564:Herpesviridae / Q000276:immunology*; D004854:Herpesvirus 4, Human / Q000276:immunology; D006689:Hodgkin Disease / Q000276:immunology; D006801:Humans; D007244:Infectious Mononucleosis / Q000276:immunology; D007938:Leukemia / Q000276:immunology*; D008223:Lymphoma / Q000276:immunology*; D016403:Lymphoma, Large B-Cell, Diffuse / Q000276:immunology; D008228:Lymphoma, Non-Hodgkin / Q000276:immunology; D008875:Middle Aged; D009303:Nasopharyngeal Neoplasms / Q000276:immunology*
D000906:Antibodies; D000941:Antigens; D000956:Antigens, Viral